APA aipamena

Chang, C., Lin, J., Chen, S., Lai, M., Chuang, L., & Chang, Y. (2016). Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study. Medicine (Baltimore).

Chicago Style aipamena

Chang, Chia-Hsuin, Jou-Wei Lin, Shu-Ting Chen, Mei-Shu Lai, Lee-Ming Chuang, and Yi-Cheng Chang. "Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study." Medicine (Baltimore) 2016.

MLA aipamena

Chang, Chia-Hsuin, et al. "Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study." Medicine (Baltimore) 2016.